These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 31673695)

  • 1. Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.
    Boyce AM; Collins MT
    Endocr Rev; 2020 Apr; 41(2):345-70. PubMed ID: 31673695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
    Spencer T; Pan KS; Collins MT; Boyce AM
    Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
    Robinson C; Collins MT; Boyce AM
    Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
    Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
    Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and eye involvement in McCune-Albright Syndrome: clinical and translational insights.
    Mascioli I; Iapadre G; Ingrosso D; Donato GD; Giannini C; Salpietro V; Chiarelli F; Farello G
    Front Endocrinol (Lausanne); 2023; 14():1092252. PubMed ID: 37274327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS).
    Vado Y; Manero-Azua A; Pereda A; Perez de Nanclares G
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38255009
    [No Abstract]   [Full Text] [Related]  

  • 7. McCune-Albright syndrome.
    Dumitrescu CE; Collins MT
    Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
    Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
    Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.
    de Castro LF; Ovejero D; Boyce AM
    Eur J Endocrinol; 2020 May; 182(5):R83-R99. PubMed ID: 32069220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Craniofacial Fibrous Dysplasia: Clinical and Therapeutic Implications.
    Szymczuk V; Taylor J; Boyce AM
    Curr Osteoporos Rep; 2023 Apr; 21(2):147-153. PubMed ID: 36849642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.
    Collins MT; Singer FR; Eugster E
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S4. PubMed ID: 22640971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
    Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrous dysplasia of bone: craniofacial and dental implications.
    Burke AB; Collins MT; Boyce AM
    Oral Dis; 2017 Sep; 23(6):697-708. PubMed ID: 27493082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
    Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
    Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
    Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
    J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. McCune-Albright syndrome: clinical picture and natural history in children and adolescents.
    Völkl TM; Dörr HG
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():551-9. PubMed ID: 16789617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome.
    Weinstein LS
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P120-4. PubMed ID: 17229000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune-Albright Syndrome, a Genetic Mosaic Disorder.
    Weidner LD; Wakabayashi Y; Stolz LA; Collins MT; Guthrie L; Victorino M; Chung J; Miller W; Zoghbi SS; Pike VW; Fujita M; Innis RB; Boyce AM
    J Nucl Med; 2020 Nov; 61(11):1672-1677. PubMed ID: 32284396
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.